Top Brand
Salt CompositionOur Recommendation
Eptoin 300mg Tablet ER 30s
2,752+ trust this
WHO GMP Certified
2,752+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment and prevention of Epilepsy/Seizures
Customers also bought
More About Eptoin 300mg Tablet ER 30s
Benefits
In Treatment and prevention of Epilepsy/Seizures Eptoin 300 ER Tablet is an anticonvulsant (or anti-epileptic) medicine that works by decreasing the nerve impulses which cause the seizures. By controlling the frequency of seizures, it will help you go about your daily activities with more confidence. It helps reduce symptoms such as confusion, uncontrollable jerking movements, loss of awareness, and fear or anxiety. This medicine is not associated with any physical or psychological dependence (addiction) but it should not be stopped suddenly. It must be taken regularly as prescribed to be effective. Missing doses may trigger a seizure.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Eptoin 300 ER Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Eptoin 300 ER Tablet is an antiepileptic medication. It controls seizures or fits by decreasing the abnormal and excessive activity of the nerve cells in the brain.
Unsafe: Avoid consuming alcohol with Eptoin 300 ER Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Eptoin 300 ER Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Safe when prescribed by an expert: Eptoin 300 ER Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby. Doctor consultation is advised.
Not Safe: Eptoin 300 ER Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Caution Advised: Eptoin 300 ER Tablet should be used with caution in patients with kidney disease. Dose adjustment of Eptoin 300 ER Tablet may be needed. Doctor consultation is advised.
Caution Advised: Eptoin 300 ER Tablet should be used with caution in patients with liver disease. Dose adjustment of Eptoin 300 ER Tablet may be needed. Doctor consultation is advised.
What if I forget to take it?
If a dose of Eptoin 300 ER Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
16th Floor, Godrej BKC, Plot ‚ C, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai ‚ 400 051, India
References
McNamara JO. Pharmacotherapy of the Epilepsies. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 591-93
Porters RJ, Meldrum BS. Antiseizure Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 403-405
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1111-116
Phenytoin. Cedex, France: Famar Orleans; 2018 (22 Mar. 2019)
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (22 Mar. 2019)
Phenytoin. New York, New York: Pfizer; 2009] (22 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (22 Mar. 2019)
Phenytoin sodium (28 Mar. 2023)
Phenytoin (31 May 2024)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
